The MarketWatch News Department was not involved in the creation of this content. - Exl-111 is an investigational allergic Effector Cell Response Inhibitor (ECRI) targeting the IgE axis and is ...
(MENAFN- GlobeNewsWire - Nasdaq) - Exl-111 is an investigational allergic Effector Cell Response Inhibitor (ECRI) targeting the IgE axis and is designed to disarm allergic effector cells at the source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results